References
- Lydtin H., Trenkwalder P. in Calcium Antagonists. A Critical Review, H. Lydtin, P. Trenkwalder. Springer-Verlag, Berlin 1988
- Höffer D. Hipertonie Therapiewoche 1985; 35: 3638–3642
- Collste P., Danielsson M., Eimfeldt D., Feleke E., Gelin A., Hedner T., Rydén L. Drugs 1985; 29(suppl. 2)124–130
- Bolli Bühler F. R.P., Kiowski W., Müller F. B. Ca-Antagonisten und Betarezeptorenblocker in der Behandlung von Hypertonic und Koronarer Herzkrankhit, A. Distler. Schattauer, Stuttgart 1986
- MacLean D. Drugs 1988; 35(suppl. 4)16–21
- Nayler W. G. Drugs 1988; 35(suppl. 4)1–8
- Challenor V. F., Waller D. G., Renwick A. G., George C. F. Br. J. Clin. Pharm. 1989; 28: 509–516
- Fitzsimons T. J., Norris S. C., Adam H. K., Ryan J., McAinsh J. Biopharm. Drug Dispos. 1991; 12: 81–94
- Ekelund L. G., Ekalund C., Rössner S. Acta Med. Scand. 1982; 212: 71–75
- De Divitiis O., Petitto M., Di Somma S., Galderisi M., Villari B., Santomauro M., Fazio S. Arzneim. Forsch. Drug Res. 1985; 35: 727–729
- Iglesias R., Taboada C., Souto C., Mart R., Anez-Pachecogómez-Amoza J. L., Concheiro A. Pharmazie 1997; 52: 717–720
- Eisen A., Miller D. K., Woodward R. S. Arch. Intern. Med. 1990; 150: 1881–1884
- Sica D. A. Drugs 1994; 48(suppl. 1)16–24
- Martindale. Extrapharmacopoeia, 31st ed. The Pharmaceutical Press, London 1996
- Anderton J. L., Vallance B. D., Stanley N. N. Drugs 1988; 35(suppl. 4)22–26
- Rees-Jones D. I. Drugs 1988; 35(suppl. 4)36–38
- Stanley N. N., Thirkettle J. L., Varma M. P. S. Drugs 1988; 35(suppl. 4)29–35
- Fitzgerald J. D., Ruffin R., Smedtad K. G., Roberts R., McAinsh J. Eur. J. Clin. Pharmacol. 1978; 13: 81–89
- Heel R. C., Brogden R. N., Speight T. M. Drugs 1979; 17: 425–460
- Taylor D. C. Development of Drugs and Modern Medicines, J. W. Gorrod, G. G. Gibson, M. Mitchard. Ellis Horwood, Chichester 1988
- Kleinbloesem C. H., Van Brummelen P., Van de Linde J. A., Voogd P. J., Breimer D. D. Clin. Pharmacol. Ther. 1984; 35: 742–749
- Kleinbloesem C. H., Van Brummelen P., Danhof M., Faber H., Urquhart J. Clin. Pharmacol. Ther. 1987; 41: 26–30
- Murdoch D., Brogden R. N. Drugs 1991; 41: 737–776
- Castañeda-Hernández G., Caille G., Du P. Souich. Clin. Pharmacokinet. 1994; 26: 135–143
- Pezoa R., Jimenez J., Arancibia A., Gaete G. An. Real Acad. Farm. 1988; 54: 589–603
- Chiou W. L., Riegelman S. J. Pharm. Sci. 1971; 60: 1281–1302
- Sumnu M. S.T.P. Pharma 1986; 2: 214–220
- Sangalli M. E., Giunchedi P., Colombo P., Conte U., Gazzaniga A., La A. Manna. Boll. Chim. Farm. 1989; 7–8: 242–247
- Koenigbauer M. J. LC-GC Int. 1989; 2: 61–63
- Korsmeyer R., Gurny R., Doclker E., Buri P., Peppas N. A. Int. J. Pharm. 1983; 15: 25–35
- Aoki S., Okamoto A., Danjo K., Sunada H., Otuka A. Drug Dev. Ind. Pharm. 1997; 23: 561–565
- Botha S. A., Lötter A. P. Drug Dev. Ind. Pharm. 1990; 16: 1945–1954